Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 320 Leukemia, Myeloid, Acute 266 Multiple Myeloma 227 Carcinoma, Non-Small-Cell Lung 224 Prostatic Neoplasms 202 Neoplasms 196 Lymphoma 191 Colorectal Neoplasms 184 Melanoma 179 Leukemia 170 Recurrence 164 Pancreatic Neoplasms 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 160 Lung Neoplasms 150 Glioblastoma 134 Neoplasm Metastasis 132 Lymphoma, Non-Hodgkin 128 Ovarian Neoplasms 123 Leukemia, Lymphocytic, Chronic, B-Cell 120 Myelodysplastic Syndromes 117 Lymphoma, Large B-Cell, Diffuse 110 Lymphoma, Mantle-Cell 108 Carcinoma, Hepatocellular 103 Lymphoma, Follicular 99 Stomach Neoplasms 96 Carcinoma, Renal Cell 89 Hodgkin Disease 88 Brain Neoplasms 88 Sarcoma 84 Burkitt Lymphoma 75

Interventions

Everolimus 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER × Advanced Malignancies × Clear all

NCT01079702 2010-03-03

m-TOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Unknown

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡